Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;40(9):2082-2089.
doi: 10.1111/liv.14548. Epub 2020 Jul 26.

Comparison of MAFLD and NAFLD diagnostic criteria in real world

Su Lin  1 , Jiaofeng Huang  1 , Mingfang Wang  1 , Rahul Kumar  2 , Yuxiu Liu  1 , Shiying Liu  1 , Yinlian Wu  1 , Xiaozhong Wang  3 , Yueyong Zhu  1
Affiliations

Comparison of MAFLD and NAFLD diagnostic criteria in real world

Su Lin et al. Liver Int. 2020 Sep.

Abstract

Background and aims: Metabolic associated fatty liver disease (MAFLD) is a novel concept proposed in 2020, the utility of which has not been tested and validated in real world. We aimed to compare the characteristics of MAFLD and non-alcoholic fatty liver disease (NAFLD).

Methods: The data was retrieved from the third National Health and Nutrition Examination Surveys of the United States, which is an unbiased survey dataset and frequently used for the study of fatty liver disease.

Results: A total of 13 083 cases with completed ultrasonography and laboratory data were identified from the NHANES III database. MAFLD was diagnosed in 4087/13 083 (31.24%) participants, while NAFLD in 4347/13 083 (33.23%) amongst the overall population and 4347/12 045 (36.09%) in patients without alcohol intake and other liver diseases. Compared with NAFLD, MAFLD patients were significantly older, had higher BMI level, higher proportions of metabolic comorbidities (diabetes, hypertension) and higher HOMA-IR, lipid and liver enzymes. MAFLD patients with alcohol consumption were younger than those without, and more likely to be male. They had less metabolic disorder but higher liver enzymes. There were more cases with advance fibrosis in MAFLD patients with alcohol consumption.

Conclusion: MAFLD definition is more practical for identifying patients with fatty liver disease with high risk of disease progression.

Keywords: NHANES; diagnosis; metabolic associated fatty liver disease; non-alcoholic fatty liver disease.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD). 2016;64:73-84.
    1. Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11-20.
    1. Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. New Engl J Med. 2017;377:2063-2072.
    1. Boyle M, Masson S, Anstee QM. The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease. J Hepatol. 2018;68:251-267.
    1. The Lancet Gastroenterology & Hepatology. Redefining non-alcoholic fatty liver disease: what's in a name? The lancet. Gastroenterol Hepatol. 2020;5:419.

Publication types

LinkOut - more resources